Shire Submits BLA for Fabry Drug to Combat Shortage

Drug Industry Daily
A A
Less than six months after a shortage of a Fabry disease treatment was announced, Shire has filed a BLA for Replagal to treat the rare illness.

To View This Article:

Login

Subscribe To Drug Industry Daily